IL-12 Exacerbates Helminth-Mediated Corneal Pathology by Augmenting Inflammatory Cell Recruitment and Chemokine Expression

Journal of Immunology

Volumn 158, Issue 2, 1997, Pages 827-833

  Pearlman, Eric ^a,b   Lass, Jonathan H ^a   Bardenstein, David S ^a   Diaconu, Eugenia ^a   Hazlett Jr , Fred E ^a   Albright, Jamie ^a   Higgins, Alan W ^a   Kazura, James W ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; INTERLEUKIN 12; PARASITE ANTIGEN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; DRUG EFFECT; DRUG POTENTIATION; EOSINOPHIL; IMMUNOLOGY; KERATITIS; MONOCYTE; MOUSE; NEUTROPHIL CHEMOTAXIS; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARASITOLOGY; PATHOGENICITY; PATHOLOGY;

ANIMALS; ANTIGENS, HELMINTH; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; EOSINOPHILS; INTERLEUKIN-12; KERATITIS; MICE; MICE, INBRED BALB C; MONOCYTES; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS;

EID: 0031567977     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. lmmunol. 13:251.
2. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. Wolf, and B. R. Bloom 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. lmmunol. 155:2515.
3. Heinzel, F., D. Schoenhaut, R. Rerko, L. Rosser, and M. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
4. Hunter, C. A., E. Candolfi, C. Subauste, C. V. Van, and J. S. Remington. 1995. Studies on the role of interleukin-12 in acute murine toxoplasmosis. Immunology 84:16.
5. Heinzel, F. P., R, M. Rerko, F. Ahmed, and E. Pearlman. 1995. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155:730.
6. Murray, H. W., and J. Hariprashad. 1995. Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181:387.
7. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin 12 induction of interferon gamma-dependent protection against malaria. Proc. Nail Acad. Sci. USA 91:10700.
8. Sypek, J., C. Chung, S. Mayor, J. Subramanyam, S. Goldman, D. Sieburth. S. Wolf, and R. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797.
9. Zhou, P., M. C. Sieve, J. Bennett, C. K. Kwon, R. P. Tewari, R. T. Gazzinelli. A. Sher, and R. A. Seder. 1995. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. J. Immunol. 155:785.
10. Afonso, L., T. Scharton, L. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin 12 in a vaccine against Leishmania major. Science 263:235.
11. Wynn, T. A., A. W. Cheever, D. Jankovic, R. W. Poindexter, P. Caspar, F. A. Lewis, and A. Sher. 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376:594.
12. Finkelman, F., K. Madden, A. Cheever, I. Katona, S, Morris, M. Gately. B. Hubbard, W. Gause, and J. Urban, Jr. 1994. Effect of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J. Exp. Med. 179:1563.
13. Trembleau, S., G. Penna, E. Bosi, A. Mortara, M. K. Gately, and L. Adorini. 1995. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817.
14. Waldburger, K., R. Hastings, R. Schaub, S. Goldman, and J. Leonard. 1996. Adoptive transfer of experimental allergic encephalomyelitis after in vivo treaiment with recombinant murine IL-12. Am. J. Pathol. 148:375.
15. + T cell . development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response. Eur. J. Immunol. 26:2606.
16. Maguire, H. J. 1995. Murine recombinant interleukin-12 increases the acquisition of allergic contact dermatitis in the mouse. Int. Arch. Allergy Immunol. 106:106.
17. Gavett, S., D. O'Hearn, X. Li, S. Huang, F. Finkelman, and W.-K.M. 1995. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182:1527.
18. Wynn, T., I. Eltoum, I. Oswald, A. Cheever, and A. Sher. 1994. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansani and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179:1755.
19. Pearlman, E., J. H. Lass, D. S. Bardenstein, M. Kopf, F. E. Hazlett, G. Diaconu, and J. W. Kazura. 1995. Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness). J. Exp. Med. 182:931.
20. Pearlman, E., J. H. Lass, D. S. Bardenstein, E. Diaconu, F. E. Hazlett, J. L. Albright, A. W. Higgins, and J. W. Kazura, 1996. Onchocerca volvulus-mediated keratitis: cytokine production by IL-4 deficient mice. Exp. Parasitai 84:274.
21. Pearlman, E., F. Heinzel, F. J. Hazlett, and J. Kazura. 1995. IL-12 modulation of T helper responses to the filarial helminth, Brugia malayi. J. Immunol. 154:4658.
22. Hendricks, R. L., P. C. Weber, J. L. Taylor, A. Koumbis, T. M. Tumpey, and J. C. Glorioso. 1991. Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease. J. Gen. Virol. 72:1601.
23. Luna, L. 1968. Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology. McGraw-Hill, New York, p. 111.
24. World Health Organization Expert Committee on Onchocerciasis. 1995. Onchocerciasis and Its Control, World Health Organization Technical Report Series Vol. 852. World Health Organization, Geneva.
25. World Health Organization Expert Committee on Onehocerciasis. 1987. Third Report, World Health Organization Technical Report Series Vol. 752. World Health Organization, Geneva.
26. Pearlman, E., and J. H. Lass. 1994. Keratitis due to Onchocerciasis. In: Ophthalmology Clinics of North America. K. R. Wilhelmus and T. J. Liesegang, eds. W. B. Saunders, Philadelphia, pp. 641-648.
27. Pearlman, E. 1996, Experimental onchocercal keratitis. Parasitai Today 12:261.
28. Bliss, J., C. V. Van, K. Murray, A. Wiencis, M. Ketchum, R. Maylor, T. Haire, C. Resmini, A. K. Abbas, and S. F. Wolf. 1996. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J. Immunol. 156:887.
29. Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv. Immunol. 55:97.
30. Collins, P. D., S. Marleau, J. D. Griffiths, P. J. Jose, and T. J. Williams. 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1169.
31. Griffiths, J. D., P. D. Collins, A. G. Rossi, P. J. Jose, and T. J. Williams. 1993. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem. Biophys. Res. Commun. 197:1167.
32. Ponath, P., S. Qin, D. Ringler, I. Clark-Lewis, J. Wang, N. Kassam, H. Smith, X. Shi, J. Gonzalo, W. Newman, J. Guitierrez-Ramos, and C. Mackay. 1996. Cloning of the human eosinophil chemoattractant, eotaxin: expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97:604.
33. Ganzalo, J. A., G. Q. Jia, V. Aguirre, D. Friend, A. J. Coyle, N. A. Jenkins, G. S. Lin, H. Katz, A. Lichtman, N. Copeland, M. Kopf, and J. C. Gutierrez-Ramos. 1996. Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity 4:1.
34. Garcia-Zepeda, E. A., M. E. Rothenberg, R. O. Ownbey, J. Celestin, P. Leder, and A. D. Luster. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanisms to explain tissue eosinophilia. Nat. Med. 2:449.
35. Rothenberg, M. E., R. O. Ownbey, P. D. Mehlhop, P. M. Loiselle, M. Van de Rijn, J. V. Bonventre, H. C. Oettgen, P. Leder, and A. D. Luster. 1996. Eotaxin triggers chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol. Med. 2:334.
36. Chensue, S. W., K. S. Warmington, N. W. Lukacs, P. M. Lincoln, M. D. Burdick, R. M. Stricter, and S. L. Kunkel. 1995. Monocyte chemotactic protein expression during schistosome egg granuloma formation. Sequence of production, localization, contribution, and regulation. Am. J. Pathol. 146:130.
37. Lukacs, N. W., S. L. Kunkel, R. M. Stricter, K. Warmington, and S. W. Chensue. 1993. The role of macrophage inflammatory protein 1 alpha in Schistosoma mansoni egg-induced granulomatous inflammation. J. Exp. Med. 177:1551.
38. Xu, H., N. Dilulio, and R. Fairchild. 1996. T cell populatioas primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: EFN-γ. J. Exp. Med. 183:1001.
39. Car, B., V. Eng, B. Schnyder, M. Lehir, A. Shakov, G. Woerly, S. Huang, M. Aguet, T. Andersen, and B. Ryffel. 1995. Role of IFN-γ. Am. J. Pathol. 147:1693.
40. Weller, P. F. 1991. The immunobioloay of eosinophils. N. Engl. J. Med. 324: 1110.
41. Rollins, B. J. T. Yoshimura, E. J. Leonard, and J. S. Pober. 1990. Cytokine activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am. J. Pathol. 136:1229.
42. Rothenherg, M. E., A. D. Luster, and P. Leder. 1995. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc. Natl. Acad. Sci. USA 92:8960.
43. Tannenbaum, C., N. Wicker, D. Armstrong, R. Tubbs, J. Finke, R. Bukowski. and T. Hamilton. 1996. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. J. Immunol. 156:693.